Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia

International Journal of Hematology

Volumn 98, Issue 3, 2013, Pages 319-322

  Sakamoto, Tatsuhiro ^a   Obara, Naoshi ^a   Kurita, Naoki ^a   Sakata Yanagimoto, Mamiko ^a   Nishikii, Hidekazu ^a   Yokoyama, Yasuhisa ^a   Suzukawa, Kazumi ^a   Hasegawa, Yuichi ^a   Chiba, Shigeru ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aplastic anemia; ATG; Immunosuppressive therapy

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; INFECTION; JAPANESE; LIVER FUNCTION; LIVER INJURY; MALE; SIDE EFFECT; TREATMENT RESPONSE;

ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884673981     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1418-5     Document Type: Article

References (18)

1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-19.
2. Kojima S, Nakao S, Young N, Bacigalupo A, Gerard G, Hirano N, et al. The Third Consensus Conference on the treatment of aplastic anemia. Int J Hematol. 2011;93:832-7.
3. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101:1236-42.
4. Locasciulli A, Oneto R, Bacigalupo A, Socié G, Korthof E, Bekassy A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2007;92:11-8.
5. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43-70.
6. Guinan EC. Diagnosis and management of aplastic anemia. Hematol Am Soc Hematol Educ Program. 2011; 76-81.
7. Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, et al. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2006;107:1308-14.
8. Camitta BM. What is the definition of cure for aplastic anemia? Acta Haematol. 2000;103:16-8.
9. Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, et al. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anemia Working Party. Blood. 2012;119:5391-6.
10. Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365:430-8.
11. Afable MG, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, et al. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica. 2011;96:1269-75.
12. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and cyclosporine for patients with relapsed or refractory severe aplastic anemia. Br J Haematol. 2006;133:622-7.
13. Shin SH, Lee JW. The optimal immunosuppressive therapy for aplastic anemia. Int J Hematol. 2013;97:564-72.
14. Shin SH, Yoon JH, Yahung SA, Lee SE, Cho BS, Eom KS, et al. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol. 2013;92:817-24.
15. Di Bona E, Rodeghiero F, Bruno B, Gabbas A, Fao Po, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol. 1999;107:330-4.
16. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and cyclosporine for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol. 2006;133:622-7.
17. Stadler M, Germing U, Kliche KO, Josten KM, Kuse R, Hofmann WK, et al. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia. 2004;18:460-5.
18. Nakao S, Sugimori C, Yamazaki H. Clinical significance of a small population of paroxysmal nocturnal hemoglobinuria-type cells in the management of bone marrow failure. Int J Hematol. 2006;84:118-22.